XML 48 R31.htm IDEA: XBRL DOCUMENT v3.24.2.u1

Equity Plans and Stock-based Compensation (Tables)

6 Months Ended

Jul. 31, 2024

Share-Based Payment Arrangement [Abstract]

Schedule of Stock-based Compensation Expense

The following sets forth the total stock-based compensation expense for employee equity plans included in the Company’s condensed consolidated statements of operations:

			Three Months Ended July 31,												Six Months Ended July 31,
			2024						2023						2024						2023
			(in thousands)
Cost of revenue			$	1,526					$	1,938					$	2,610					$	2,933
Research and development			10,731						15,847						19,033						25,353
Sales and marketing			4,463						6,757						9,905						10,926
General and administrative			2,049						10,557						8,820						19,851
Total stock-based compensation expense			$	18,769					$	35,099					$	40,368					$	59,063

Schedule of Share-based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity

A summary of RSUs outstanding under the 2021 EIP as of July 31, 2024 and changes during the fiscal year-to-date period then ended is presented in the following table:

			Number of Shares						Weighted Average Grant Date Fair Value per Share
Outstanding as of January 31, 2024			28,416,127						$	7.35
RSU granted			22,271,093						$	1.51
RSU vested			(5,231,209)						$	7.09
RSU forfeited			(4,428,242)						$	9.77
Outstanding as of July 31, 2024			41,027,769						$	3.95

A summary of PRSUs outstanding under the 2021 EIP as of July 31, 2024 and changes during the fiscal year-to-date period then ended is presented in the following table:

			Number of Shares						Weighted Average Grant Date Fair Value per Share
Outstanding as of January 31, 2024			3,147,782						$	6.79
PRSUs granted			1,208,250						$	1.26
PRSU forfeited			(1,170,008)						$	10.47
Outstanding as of July 31, 2024			3,186,024						$	3.34

Schedule of Share-based Payment Arrangement, Option, Activity

A summary of options outstanding under the 2017 Plan and 2007 Plan as of July 31, 2024 and changes during the fiscal year-to-date period then ended is presented in the following table:

			Number of Stock Option Awards						Weighted Average Exercise Price						Weighted Average Remaining Contractual term (in years)						Aggregate Intrinsic Value (in thousands)
Outstanding as of January 31, 2024			11,396,756						$	0.74					4.8						$	13,276
Options exercised			(2,629,090)						$	0.58
Options cancelled			(76,860)						$	0.74
Outstanding as of July 31, 2024			8,690,806						$	0.78					2.2						$	12,061
Options vested and expected to vest as of July 31, 2024			8,690,806						$	0.78					2.2						$	12,061
Exercisable as of July 31, 2024			8,690,806						$	0.78					2.2						$	12,061

X

- References

No definition available.

+ Details

Name:	us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (h)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (d)
-SubTopic 10
-Topic 718
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (e)
-SubTopic 10
-Topic 718
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year.

+ References

No definition available.

+ Details

Name:	us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration